Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant

NCT02945150 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Renal Failure

Interventions

DRUG: elbasvir (50mg) / grazoprevir (100mg) (fixed dose combination)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]